MERCK KGAA/S (MKKGY) Receives “Neutral” Rating from UBS Group

MERCK KGAA/S (OTCMKTS:MKKGY)‘s stock had its “neutral” rating reaffirmed by UBS Group in a report issued on Friday, www.briefing.com reports.

OTCMKTS MKKGY traded down $0.55 during trading on Friday, hitting $22.15. The stock had a trading volume of 232 shares, compared to its average volume of 20,124. MERCK KGAA/S has a one year low of $18.53 and a one year high of $22.76.

About MERCK KGAA/S

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. The company offers prescription medicines to treat infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, multiple sclerosis, and colorectal cancer, as well as carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

Read More: What causes a recession?

Receive News & Ratings for MERCK KGAA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK KGAA/S and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply